Clare Wareing, Managing Director at Cumulus Oncology, Edinburgh, Edinburgh, City of, United Kingdom — verified investor profile. See contact routes.
Cumulus Oncology focuses on turning top-tier science into differentiated oncology assets with real patient impact. Their approach to portfolio building is platform-agnostic, data and milestone-driven, prioritizing successful outcomes for individual programs. They aim to improve success rates in drug discovery and development, translating preclinical-stage assets into later-stage clinical success. They embed a precision, patient-focused development strategy and proactively manage their asset portfolio through internal ideation, external validation, and strategic alliances with drug discovery partners. They expand their pipeline with externally sourced assets for patient subgroups with unmet medical needs, managing risk and reward through asset portfolio curation and assessing market fit for M&A or partnering activities with Pharma companies.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Edinburgh when building a target list.
Investors like Clare Wareing · Full investor directory · Investor access · Company funding database